Positive data from ongoing studies has provided Proteome Sciences PLC with further evidence of the potential of its TMTcalibrator and SysQuant proteomic technologies to detect the onset of Alzheimer's disease earlier than any other method.
In a series of papers presented at the recent Alzheimer’s Association International Conference (AAIC) in Washington, July 18-23, three presentations...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?